Physician profile
David M Wilhelm
NPI 1326039959
$5,621.15
in general payments reported to CMS, 2019-2025
32 companies · $1,076 in 2025
The $1,076 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $923 · 2020: $546 · 2021: $646 · 2022: $895 · 2023: $911 · 2024: $624 · 2025: $1,076.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,611.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,611.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,184.16 | 2019-2025 | Myrbetriq, Xtandi |
| Pfizer INC. | $573.62 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $550.04 | 2019-2025 | Provenge |
| Abbvie INC. | $482.20 | 2019-2025 | Botox |
| Boston Scientific Corporation | $389.56 | 2019-2024 | Spaceoar Vue System - 10ml |
| Sumitomo Pharma America, INC. | $339.86 | 2023-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $266.39 | 2022-2025 | Jelmyto |
| Janssen Biotech, INC. | $223.86 | 2019-2025 | Erleada |
| Myriad Genetic Laboratories, INC. | $217.04 | 2020-2023 | Prolaris |
| Procept Biorobotics Corporation | $174.93 | 2024-2025 | Aquabeam System |
| Merck Sharp & Dohme LLC | $147.43 | 2022-2024 | Lynparza, Welireg, Keytruda |
| Intuitive Surgical, INC. | $99.71 | 2025 | |
| Urovant Sciences INC | $89.28 | 2021-2022 | |
| Accord Healthcare, INC. | $81.30 | 2025 | |
| Novartis Pharmaceuticals Corporation | $74.27 | 2024-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $70.38 | 2022-2023 | Titan, Speedicath |
| Amgen INC. | $66.53 | 2019-2021 | |
| Tolmar Pharmaceuticals, INC. | $64.13 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.64 | 2021-2022 | |
| Myovant Sciences INC. | $48.58 | 2021-2022 | |
| Allergan, INC. | $47.32 | 2019-2021 | |
| Teleflex LLC | $45.39 | 2022-2024 | Urolift |
| 180 Medical, INC. | $43.08 | 2019-2023 | |
| Laborie Medical Technologies Corp. | $40.39 | 2022-2025 | |
| Ethicon US, LLC | $40.14 | 2025 | Vistaseal |
| Olympus America INC. | $39.94 | 2023-2025 | Soltive, Itind System |
| Sun Pharmaceutical Industries INC. | $39.54 | 2019-2022 | |
| Blue Earth Diagnostics | $32.90 | 2022-2024 | |
| Genzyme Corporation | $32.56 | 2019 | |
| Cook Medical LLC | $26.73 | 2023 | Fiber Dust |
| Antares Pharma, INC. | $16.51 | 2019 | |
| Cycle Pharmaceuticals INC | $13.74 | 2025 | Venxxiva |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Wilhelm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.